PD 135158

PD 135158 Suppliers list
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Tel: 18930552037
Email: 3bsc@sina.com
Company Name: EMMX Biotechnology LLC  
Tel: 888-539-0666
Email: info@emmx.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Company Name: RD International Technology Co., Limited  
Tel: 18024082417
Email: market@ubiochem.com
PD 135158 Basic information
Product Name:PD 135158
Synonyms:PD 135158;4-[[(1R)-2-[[(2R)-3-(1H-Indol-3-yl)-2-methyl-1-oxo-2-[[[[(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]oxy]carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxobutanoicacid
CAS:130325-35-8
MF:C42H61N5O11
MW:811.97
EINECS:
Product Categories:
Mol File:130325-35-8.mol
PD 135158 Structure
PD 135158 Chemical Properties
storage temp. Store at +4°C
solubility <61.68mg/ml in DMSO
Safety Information
MSDS Information
PD 135158 Usage And Synthesis
UsesPD 135158 (CAM 1028) is a selective CCKB receptor antagonist with an IC50 of 2.8 nM against mouse cortex CCKB. PD 135158 shows anxiolytic activity[1].
Biological ActivityPotent and selective, nonpeptide CCK 2 receptor antagonist (IC 50 values are 2.8 and 1232 nM for CCK 2 and CCK 1 respectively) that displays negligible affinity at GABA A , benzodiazepine, substance P, neurotensin, opioid, bradykinin and 5-HT 3 receptors (IC 50 > 10 μ M). Exhibits anxiolytic activity in elevated plus maze and social interaction tests and increases food intake in rats.
in vivo

PD 135158 (CAM 1028; 0.001-0.1 mg/kg; s.c.; once) enhances latent inhibition in the rat and shows antipsychotic potential[2].

Animal Model:Male Sprague-Dawley rats, conditioned suppression of drinking procedure model[2]
Dosage:0.001, 0. 01, and 0.1 mg/kg
Administration:0.2 mL/kg SC 30 min before prexposure and conditioning
Result:Elicited a clear latent inhibition effect under conditions that did not lead to latent inhibition in control rats.
IC 50CCKBR: 2.8 nM (IC50); CCKAR: 1232 nM (IC50)
References[1] Hughes J, et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6728-32. DOI:10.1073/pnas.87.17.6728
[2] Gracey DJ, et al. PD-135,158, a cholecystokinin(B) antagonist, enhances latent inhibition in the rat. Pharmacol Biochem Behav. 2000 Mar;65(3):459-63. DOI:10.1016/s0091-3057(99)00227-0
PD 135158 Preparation Products And Raw materials
Tag:PD 135158(130325-35-8) Related Product Information
L(-)-Borneol PD 135158 endo-1,7,7-Trimethylbicyclo(2.2.1)-2-heptanol, 97% BORNYL FORMATE methyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3-(1H-indol-3-yl)propanamido)-3-cyclohexylpropanoate TROXIPIDE